Pharvaris N.V. (PHVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 214,312 | 218,576 | 247,686 | 257,768 | 270,281 |
| Receivables | 353 | 751 | 828 | 746 | 859 |
| Income taxes - deferred | 106 | 153 | 204 | 138 | 124 |
| Other current assets | 4,869 | 5,838 | 1,791 | 3,992 | 5,098 |
| TOTAL | $219,641 | $225,318 | $250,508 | $262,644 | $276,361 |
| Non-Current Assets | |||||
| PPE Net | 151 | 142 | 128 | 115 | 90 |
| Other Non-Current Assets | 224 | 250 | 288 | 310 | 344 |
| TOTAL | $375 | $392 | $416 | $425 | $435 |
| Total Assets | $220,016 | $225,710 | $250,924 | $263,069 | $276,796 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,437 | 3,766 | 2,947 | 4,536 | 4,028 |
| Accrued Expenses | 9,558 | 7,331 | 5,052 | 4,300 | 4,777 |
| TOTAL | $17,099 | $11,357 | $8,265 | $8,836 | $8,805 |
| Non-Current Liabilities | |||||
| TOTAL | $109 | $138 | $178 | $202 | $228 |
| Total Liabilities | $17,207 | $11,494 | $8,444 | $9,038 | $9,033 |
| Shareholders' Equity | |||||
| Common Shares | 4,312 | 4,464 | 4,707 | 4,688 | 4,790 |
| Retained earnings | -123,700 | -116,255 | -103,602 | -88,533 | -79,448 |
| Other shareholders' equity | 15,600 | 13,193 | 11,595 | 9,545 | 6,934 |
| TOTAL | $202,809 | $214,217 | $242,480 | $254,031 | $267,763 |
| Total Liabilities And Equity | $220,016 | $225,711 | $250,924 | $263,069 | $276,796 |